DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
GSK-2018682
1
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
Unknown
GSK-2018682
×
Maximum Phase:
1
First Approval:
None
UNII:
NJL503AIJA
Molecule Type:
Small molecule
Molecular Formula:
C22H21ClN4O4
Molecular Weight:
440.89
AlogP:
5.06
PSA:
103.27
HBD:
1.0
HBA:
#RotB:
8.0
Source:
KL-1333
1
Small molecule
Investigational
Unknown
Unknown
MELAS Syndrome; Mitochondrial Diseases
Unknown
KL-1333
×
Maximum Phase:
1
First Approval:
None
UNII:
NA2ZOL5UGM
Molecule Type:
Small molecule
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.26
AlogP:
2.58
PSA:
62.82
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CX-157
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Unknown
CX-157
×
Maximum Phase:
1
First Approval:
None
UNII:
O6L62LZJ0Q
Molecule Type:
Small molecule
Molecular Formula:
C14H8F4O4S
Molecular Weight:
348.27
AlogP:
3.71
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ASP-5878
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ASP-5878
×
Maximum Phase:
1
First Approval:
None
UNII:
C0Z095LL72
Molecule Type:
Small molecule
Molecular Formula:
C18H19F2N5O4
Molecular Weight:
407.38
AlogP:
2.28
PSA:
103.55
HBD:
2.0
HBA:
#RotB:
9.0
Source:
TIGILANOL TIGLATE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
TIGILANOL TIGLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
R1ZJT87990
Molecule Type:
Small molecule
Molecular Formula:
C30H42O10
Molecular Weight:
562.66
AlogP:
1.23
PSA:
163.12
HBD:
4.0
HBA:
#RotB:
6.0
Source:
PUQUITINIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
PUQUITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
WFG29AB872
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
THELIATINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
THELIATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6ZZ3B7NZ0B
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06840003
1
Small molecule
Investigational
Unknown
Unknown
Astrocytoma; Oligodendroglioma
Unknown
PF-06840003
×
Maximum Phase:
1
First Approval:
None
UNII:
5K1FUI0T2C
Molecule Type:
Small molecule
Molecular Formula:
C12H9FN2O2
Molecular Weight:
232.21
AlogP:
1.44
PSA:
61.96
HBD:
2.0
HBA:
#RotB:
1.0
Source:
DSP-2230
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
DSP-2230
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETA ALETHINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BETA ALETHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIRLOTAPIDE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
DIRLOTAPIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
578H0RMP25
Molecule Type:
Small molecule
Molecular Formula:
C40H33F3N4O3
Molecular Weight:
674.72
AlogP:
8.25
PSA:
83.44
HBD:
2.0
HBA:
#RotB:
9.0
Source:
PHENSERINE, (+)-
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
PHENSERINE, (+)-
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0O4TJ588O
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O2
Molecular Weight:
337.42
AlogP:
3.67
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
2.0
Source:
GSK159802
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
GSK159802
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NIKKOMYCIN
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
NIKKOMYCIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9Z22C3QQCJ
Molecule Type:
Small molecule
Molecular Formula:
C20H25N5O10
Molecular Weight:
495.45
AlogP:
-3.48
PSA:
250.32
HBD:
8.0
HBA:
#RotB:
8.0
Source:
ETACONAZOLE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms
Unknown
ETACONAZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
3MT15AE9VG
Molecule Type:
Small molecule
Molecular Formula:
C14H15Cl2N3O2
Molecular Weight:
328.2
AlogP:
3.26
PSA:
49.17
HBD:
0.0
HBA:
#RotB:
4.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORM-13070 C-11
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ORM-13070 C-11
×
Maximum Phase:
1
First Approval:
None
UNII:
Y61S1UFN4Y
Molecule Type:
Small molecule
Molecular Formula:
C20H25N3O3
Molecular Weight:
354.44
AlogP:
2.19
PSA:
47.06
HBD:
0.0
HBA:
#RotB:
5.0
Source:
D-FLUOROMETHYLTYROSINE F-18
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE F-18
×
Maximum Phase:
1
First Approval:
None
UNII:
58HVN5SR99
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
212.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CEP-9722
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Mantle-Cell; Neoplasms
Unknown
CEP-9722
×
Maximum Phase:
1
First Approval:
None
UNII:
B68083E4YG
Molecule Type:
Small molecule
Molecular Formula:
C24H26N4O3
Molecular Weight:
418.5
AlogP:
2.62
PSA:
68.88
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LGD-6972
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
LGD-6972
×
Maximum Phase:
1
First Approval:
None
UNII:
6IJ842I0Z2
Molecule Type:
Small molecule
Molecular Formula:
C43H46N2O5S
Molecular Weight:
702.92
AlogP:
8.83
PSA:
112.57
HBD:
3.0
HBA:
#RotB:
11.0
Source:
CHF4227
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Estrogen receptor modulator
CHF4227
×
Maximum Phase:
1
First Approval:
None
UNII:
1O98089Q9M
Molecule Type:
Small molecule
Molecular Formula:
C30H33NO4
Molecular Weight:
471.6
AlogP:
5.81
PSA:
51.16
HBD:
1.0
HBA:
#RotB:
8.0
Source:
(NORTH)-METHANOCARBATHYMIDINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
(NORTH)-METHANOCARBATHYMIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
LTM5S02010
Molecule Type:
Small molecule
Molecular Formula:
C12H16N2O4
Molecular Weight:
252.27
AlogP:
-0.85
PSA:
95.32
HBD:
3.0
HBA:
#RotB:
2.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
LISAVANBULIN
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms
Unknown
LISAVANBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
5PT0QP06X5
Molecule Type:
Small molecule
Molecular Formula:
C26H29N9O3
Molecular Weight:
515.58
AlogP:
2.69
PSA:
190.77
HBD:
4.0
HBA:
#RotB:
13.0
Source:
PROPYL GALLATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PROPYL GALLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
8D4SNN7V92
Molecule Type:
Small molecule
Molecular Formula:
C10H12O5
Molecular Weight:
212.2
AlogP:
1.37
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
3.0
Source:
MEZIGDOMIDE
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
MEZIGDOMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C32H30FN5O4
Molecular Weight:
567.62
AlogP:
3.36
PSA:
105.98
HBD:
1.0
HBA:
#RotB:
7.0
Source:
SEL-120
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SEL-120
×
Maximum Phase:
1
First Approval:
None
UNII:
SDM3M518PJ
Molecule Type:
Small molecule
Molecular Formula:
C15H18Br2N4
Molecular Weight:
414.14
AlogP:
3.23
PSA:
33.09
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PHENFORMIN
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Diabetes Mellitus
Unknown
PHENFORMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
DD5K7529CE
Molecule Type:
Small molecule
Molecular Formula:
C10H15N5
Molecular Weight:
205.26
AlogP:
0.24
PSA:
97.78
HBD:
5.0
HBA:
#RotB:
3.0
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SHETA-2
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SHETA-2
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O2S2
Molecular Weight:
401.56
AlogP:
6.18
PSA:
67.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
XL-844
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
XL-844
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVE-9940
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
AVE-9940
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KW-2450
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms
Insulin-like growth factor I receptor inhibitor
KW-2450
×
Maximum Phase:
1
First Approval:
None
UNII:
2TRH1EX32K
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-2239633
1
Small molecule
Investigational
Unknown
Unknown
Asthma
Unknown
GSK-2239633
×
Maximum Phase:
1
First Approval:
None
UNII:
07ODS257BP
Molecule Type:
Small molecule
Molecular Formula:
C21H19ClN4O5S2
Molecular Weight:
506.99
AlogP:
3.54
PSA:
122.55
HBD:
3.0
HBA:
#RotB:
8.0
Source:
1
2
…
62
63
64
65
66
67
68
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA